Market News How it works Learn FAQ
| GPUS 0.1689 34.05% | SHFS 0.1324 -61.39% | XXII 0.1977 -8.34% | NVD 4.19 0.96% | LUCD 0.411 25.42% | SPCX 147.49 1.89% | T 20.93 -7.96% | SOXL 83.56 1.77% | NU 15.16 2.92% | NOK 8.14 3.30% | EWZ 42.59 1.77% | NVDA 210.96 -0.59% | RIME 0.106 -12.90% | INTC 86.96 1.72% | TSLG 4.87 -1.62% | AAL 12.11 -3.89% | BBD 4.07 3.04% | STLA 4.06 -4.81% | SOXS 52.46 -1.85% | RWM 14.55 0.34% | HYG 77.05 -0.06% | MYND 0.24 47.42% | RBNE 0.19 -2.56% | YFOR 0.2236 -1.58% | BITO 10.83 -0.28% | SPDN 8.54 0.47% | TQQQ 66.29 -0.20% | TSLL 9.76 -1.21% | VZ 44.66 -1.19% | SPTI 27.63 -0.11% | YMAT 2.05 6.77% | CRWV 54.235 -2.46% | INFY 12.35 -6.58% | RIG 6.41 5.43% | F 11.6 -2.85% | GRAB 2.79 -2.11% | AIOK 12.02 182.82% | SQQQ 39.68 0.20% | ONDS 6.2 2.99% | LABT 0.31 -36.67% | AAPL 347.725 -0.14% | CDE 13.45 -3.10% | PCG 12.63 -2.70% | IREN 24.905 -2.37% | SOFI 14.615 -1.05% | XLE 69.33 2.60% | NFLX 65.85 -1.79% | QID 14.55 0.14% | CLRO 3.25 69.27% | WULF 11.32 0.00%
TWTwist Bioscience Corporation logo

Twist Bioscience Corporation (TWST)

NASDAQ Global Select · Currency in USD
$139.92 ▲ +4.45 (+3.28%)
At close: Oct 23, 4:00 PM ET. Market closed.
$138.69 ▼ -1.23 (-0.88%)
After hours: Oct 23, 7:37 PM ET

Summary

Previous Close
$135.47
Open
$132.95
Day's Range
$131.23 – $140.74
52 Week Range
$23.30 – $219.71
Volume
1,857,985
Avg. Volume
2,119,511
Market Cap
$9.21B
Beta (5Y Monthly)
2.19
PE Ratio (TTM)
--
EPS (TTM)
-$2.19
Earnings Date
Nov 13, 2026
Forward Dividend & Yield
--
Ex-Dividend Date
--
1y Target Est
$153.70

Profile: Twist Bioscience Corporation

Sector
Healthcare
Industry
Biotechnology
Full-time employees
979
CEO
Emily Marine Leproust

Twist Bioscience Corporation operates as a leading synthetic biology firm, specializing in the production and sale of products developed from synthesized DNA. The company utilizes a unique DNA synthesis platform that facilitates the creation of artificial DNA by "writing" it directly onto silicon chips. Its extensive product catalog encompasses custom synthetic genes, specialized tools designed for sample preparation, comprehensive antibody libraries essential for pharmaceutical research and development, and advanced applications leveraging DNA for digital data storage.

Earnings

Next report: Fri, Nov 13, 2026
EPS estimate -$0.38 · Revenue est. $123.59M
DateEst.Actual
Aug 3, 2026-$0.51-$0.56Miss
May 4, 2026-$0.49-$0.71Miss
Feb 2, 2026-$0.48-$0.50Miss
Nov 14, 2025-$0.50-$0.45Beat
Aug 4, 2025-$0.54-$0.47Beat
May 5, 2025-$0.56-$0.66Miss

Analyst view

Consensus price target
$153.70 ▲ +9.8%
Range $89.00 – $215.00
Rating: Buy
Buy 73% · Hold 13% · Sell 13%

Similar stocks

Get free alerts on TWST and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.